ENS 51118: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by Mark Hawes) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
| facility = Riverside Medical Center | | facility = Riverside Medical Center | ||
| Organization = Illinois Emergency Mgmt. Agency | | Organization = Illinois Emergency Mgmt. Agency | ||
| license number = | | license number = IL-01242-01 | ||
| region = 3 | | region = 3 | ||
| state = Illinois | | state = Illinois | ||
| Line 16: | Line 16: | ||
| event date = 06/02/2015 CDT | | event date = 06/02/2015 CDT | ||
| last update date = 06/04/2015 | | last update date = 06/04/2015 | ||
| title = Agreement State Report - Medical Event Due | | title = Agreement State Report - Medical Event Due to Mis-Administration of Y-90 Sir-Spheres | ||
| event text = The following information was received via E-mail: | | event text = The following information was received via E-mail: | ||
The Director of Radiology at Riverside Medical Center, Kankakee, IL called the Agency [Illinois Emergency Management Agency] to advise that a medical event had occurred during the administration of a Y-90 SIR-Sphere treatment on the morning of June 2, 2015. 35.2 mCi of Y-90 was intended to be delivered to the patient's liver to treat metastatic cancer lesions via the hepatic artery. However, when the patient was imaged immediately following the treatment, the kidney was observed as the organ which had received the dose with no material evident in the liver. It was determined that the infusion catheter was improperly placed. Instead of placement in the patient's hepatic artery, the renal artery was the infusion site. This was the facility's first patient to undergo this treatment modality. As a result, the manufacturer's proctor was present in addition to the treatment team members which included the radiologist, the radiation safety officer, the nuclear medicine technologist as well as others. | The Director of Radiology at Riverside Medical Center, Kankakee, IL called the Agency [Illinois Emergency Management Agency] to advise that a medical event had occurred during the administration of a Y-90 SIR-Sphere treatment on the morning of June 2, 2015. 35.2 mCi of Y-90 was intended to be delivered to the patient's liver to treat metastatic cancer lesions via the hepatic artery. However, when the patient was imaged immediately following the treatment, the kidney was observed as the organ which had received the dose with no material evident in the liver. It was determined that the infusion catheter was improperly placed. Instead of placement in the patient's hepatic artery, the renal artery was the infusion site. This was the facility's first patient to undergo this treatment modality. As a result, the manufacturer's proctor was present in addition to the treatment team members which included the radiologist, the radiation safety officer, the nuclear medicine technologist as well as others. | ||
Latest revision as of 19:05, 24 November 2018
| Where | |
|---|---|
| Riverside Medical Center Kankakee, Illinois (NRC Region 3) | |
| License number: | IL-01242-01 |
| Organization: | Illinois Emergency Mgmt. Agency |
| Reporting | |
| Agreement State | |
| Time - Person (Reporting Time:+55.47 h2.311 days <br />0.33 weeks <br />0.076 months <br />) | |
| Opened: | Daren Perrero 12:28 Jun 4, 2015 |
| NRC Officer: | Donald Norwood |
| Last Updated: | Jun 4, 2015 |
| 51118 - NRC Website | |